Sleeve Gastrectomy and Liver Omentoplasty Can Increased Il-10 and TGF-Β Expression on Liver Fibrosis in Obesity
DOI:
https://doi.org/10.3889/oamjms.2022.10986Keywords:
IL-10, Liver ometoplasty, Obesity, Sleeve gastrectomy, aTGF-βAbstract
BACKGROUND: Obesity is a risk factor happening liver fibrosis because it makes presence of oxidative stress and inflammation that has role on pathogenesis and hepatic fibrosis progression. Until this moment, liver disease management still focused for treat disease primary, the most rational management of liver fibrosis is liver transplant, however number success transplant liver lower from on transplant kidneys, only 70-80% of recipients survived for at least 1 year, so that sleeve gastrectomy and liver omentoplasty procedure could become a choice for treating liver fibrosis on obese patients.
AIM: This study aims to investigate correlation between sleeve gastrectomy and omentoplasty on TGF-β and IL-10 in obese rats with liver fibrosis
METHOD: This study used a true experiment in-vivo design on male Wistar rat (Spargue Dawley) 4-6 weeks of age. Samples were divided into groups that includes normal control group, positive control group, group with sleeve gastrectomy, and group with both liver liver omentoplasty and sleeve gastrectomy. The level of TGF-β and IL-10 will be measured for descriptive and hypothesis analysis.
RESULT: There is an increased level of IL-10 and TGF-β. Statistical analysis result shows a significant increase of IL-10 and TGF-β expression between normal group and control group with group given treatment sleeve gastrectomy and liver liver omentoplasty (p<0.05).
CONCLUSION: liver Liver omentoplasty and sleeve gastrectomy procedure on obese mice with liver fibrosis could increases IL-10 expression but could not reduce (TGF-β expression).
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Soegih R, Wiramihardja K. Obesitas: Permasalahan dan Terapi Praktis. Jakarta: Sagung Seto; 2009.
World Health Organization. Obesity Update. Geneva: World Health Organisation; 2018.
Dimas E, Mughni A, Wiryawan C, Mahendra V, Riwanto I. Sleeve gastrectomy and pancreas omentoplasty improved β _cell insulin expression and interleukin-1β serum level in non-obese diabetes mellitus rat. Bali Med J. 2021;10(1):460-6. https://doi.org/10.15562/bmj.v10i1.2258 DOI: https://doi.org/10.15562/bmj.v10i1.2258
Viana EC, Araujo-Dasilio KL, Miguel GP, Bressan J, Lemos EM, Moyses MR, et al. Gastric bypass and sleeve gastrectomy: The same impact on IL-6 and TNF-α. Prospective clinical trial. Obes Surg. 2013;23(8):1252-61. https://doi.org/10.1007/s11695-013-0894-2 PMid:23475776 DOI: https://doi.org/10.1007/s11695-013-0894-2
Major P, Wysocki M, Pedziwiatr M, Malczak P, Pisarska M, Budzynski A. Laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus Type 2 patients-single center early experience. Gland Surg. 2016;5(5):465-72. https://doi.org/10.21037/gs.2016.09.04 PMid:27867860 DOI: https://doi.org/10.21037/gs.2016.09.04
Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and Type 2 diabetes mellitus: A systematic review. Surg Obes Relat Dis. 2010;6(6):707-13. https://doi.org/10.1016/j.soard.2010.07.011 PMid:20947447 DOI: https://doi.org/10.1016/j.soard.2010.07.011
Salman MA, Salman AA, Nafea MA, Sultan AA, Anwar HW, Ibrahim AH, et al. Study of changes of obesity-related inflammatory cytokines after laparoscopic sleeve gastrectomy. ANZ J Surg. 2019;89(10):1265-9. https://doi.org/10.1111/ans.15427 PMid:31508889 DOI: https://doi.org/10.1111/ans.15427
Yang AT, Hu DD, Wang P, Cong M, Liu TH, Zhang D, et al. TGF- β1 induces the dual regulation of hepatic progenitor cells with both anti-and proliver fibrosis. Stem Cells Int. 2016;2016:1492694. https://doi.org/10.1155/2016/1492694 PMid:26839553 DOI: https://doi.org/10.1155/2016/1492694
Annes JP, Munger JS, Rifkin DB. Making sense of latent TGF beta activation. J Cell Sci. 2003;116(Pt 2):217-24. https://doi.org/10.1242/jcs.00229 PMid:12482908 DOI: https://doi.org/10.1242/jcs.00229
Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22(10):1276-312. https://doi.org/10.1101/gad.1653708 PMid:18483217 DOI: https://doi.org/10.1101/gad.1653708
Zhang LJ, Wang XZ. Interleukin 10 and chronic liver disease. World J Gastroenterol. 2006;12(11):1681-5. https://doi.org/10.3748/wjg.v12.i11.1681 PMid:16586534 DOI: https://doi.org/10.3748/wjg.v12.i11.1681
Nga HT, Moon JS, Tian J, Lee HY, Kim SH, Lee YS, et al. Interleukin-10 attenuates liver fibrosis exacerbated by thermoneutrality. Front Med (Lausanne). 2021;8:672658. https://doi.org/10.3389/fmed.2021.672658 PMid:34124102 DOI: https://doi.org/10.3389/fmed.2021.672658
Ekasaputra VM, Mughni A, Putra A, Riwanto I, Nugrahadi DE, Prasetya A, et al. Combination of sleeve gastrectomy and mesenchymal stem cells improves insulin resistance by modulating pro-inflammatory milieu in obese Type 2 diabetic rat model. Open Access Maced J Med Sci. 2022;10(B):158-63. https://doi.org/10.3889/oamjms.2022.8211 DOI: https://doi.org/10.3889/oamjms.2022.8211
Downloads
Published
How to Cite
License
Copyright (c) 2022 Primadita Purnamasari, K. Heri Nugroho, Sigit Adi Prasetyo, Yan Wisnu Prajoko, Fatmala Haningtyas, Sindu Nugroho Mukti, Addy Saputro, Abdul Mughni Rozy (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
